Filing Details

Accession Number:
0001179110-20-003226
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-06 16:10:10
Reporting Period:
2020-03-05
Accepted Time:
2020-03-06 16:10:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC Services-Offices & Clinics Of Doctors Of Medicine (8011) 043705970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726568 Lewis Levy C/O Teladoc Health, Inc.
2 Manhattanville Road, Suite 203
Purchase NY 10577
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-05 3,207 $0.00 9,569 No 4 M Direct
Common Stock Disposition 2020-03-05 1,398 $132.73 8,171 No 4 F Direct
Common Stock Acquisiton 2020-03-05 2,467 $0.00 10,638 No 4 M Direct
Common Stock Disposition 2020-03-05 711 $132.73 9,927 No 4 F Direct
Common Stock Disposition 2020-03-05 1,982 $126.51 7,945 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Units Disposition 2020-03-05 3,207 $0.00 3,207 $0.00
Common Stock Restricted Stock Units Disposition 2020-03-05 2,467 $0.00 2,467 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,416 No 4 M Direct
4,935 No 4 M Direct
Footnotes
  1. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  3. Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
  4. On February 26, 2020, the reporting person earned 9,623 performance stock units, vesting in three annual installments beginning on March 4, 2020.
  5. On March 4, 2019, the reporting person was granted 7,402 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
  6. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019.